Waterloo Capital, L.P.

Position in INCY — Incyte Corp

CIK 1730942 Austin, TX

Position in INCY

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$310,266

+$6,259 QoQ

Shares Held

2,737

-15.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#153

of 264 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Waterloo Capital, L.P. holds $7,809,642 across 5 Biotechnology names. INCY ranks #3 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc.	9,926	$5,329,765
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,651	$1,813,561
3	INCY	Incyte Corp This page	2,737	$310,266
4	REGN	Regeneron Pharmaceuticals, Inc.	339	$211,380
5	DRTS	Alpha Tau Medical Ltd.	11,500	$144,670

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$310,266	2,737	-15.3%	Shares	Sole	2026-07-29
2026-03-31	$304,007	3,230	-6.0%	Shares	Sole	2026-05-12
2025-12-31	$339,274	3,435	+7.0%	Shares	Sole	2026-02-10
2025-09-30	$272,240	3,210	—	Shares	Sole	2025-11-05
No filing history on record for this holder in this stock.